Literature DB >> 26661238

Video training and certification program improves reliability of postischemic neurologic deficit measurement in the rat.

Hideki Taninishi1, Molly Pearlstein1, Huaxin Sheng1, Miwa Izutsu1, Rafael E Chaparro1, Larry B Goldstein2, David S Warner3,4.   

Abstract

Scoring systems are used to measure behavioral deficits in stroke research. Video-assisted training is used to standardize stroke-related neurologic deficit scoring in humans. We hypothesized that a video-assisted training and certification program can improve inter-rater reliability in assessing neurologic function after middle cerebral artery occlusion in rats. Three expert raters scored neurologic deficits in post-middle cerebral artery occlusion rats using three published systems having different complexity levels (3, 18, or 48 points). The system having the highest point estimate for the correlation between neurologic score and infarct size was selected to create a video-assisted training and certification program. Eight trainee raters completed the video-assisted training and certification program. Inter-rater agreement ( Κ: score) and agreement with expert consensus scores were measured before and after video-assisted training and certification program completion. The 48-point system correlated best with infarct size. Video-assisted training and certification improved agreement with expert consensus scores (pretraining = 65 ± 10, posttraining = 87 ± 14, 112 possible scores, P < 0.0001), median number of trainee raters with scores within ±2 points of the expert consensus score (pretraining = 4, posttraining = 6.5, P < 0.01), categories with Κ:  > 0.4 (pretraining = 4, posttraining = 9), and number of categories with an improvement in the Κ: score from pretraining to posttraining (n = 6). Video-assisted training and certification improved trainee inter-rater reliability and agreement with expert consensus behavioral scores in rats after middle cerebral artery occlusion. Video-assisted training and certification may be useful in multilaboratory preclinical studies.
© The Author(s) 2015.

Entities:  

Keywords:  Animal models; behavior (rodent); behavioral neurology; brain ischemia; focal ischemia

Mesh:

Year:  2015        PMID: 26661238      PMCID: PMC5363665          DOI: 10.1177/0271678X15616980

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  15 in total

Review 1.  Neuroanesthesia: from bench to bed.

Authors:  Mishiya Matsumoto; Kazuyoshi Ishida
Journal:  J Anesth       Date:  2012-02-29       Impact factor: 2.078

2.  Reliability of the National Institutes of Health Stroke Scale. Extension to non-neurologists in the context of a clinical trial.

Authors:  L B Goldstein; G P Samsa
Journal:  Stroke       Date:  1997-02       Impact factor: 7.914

3.  Interrater reliability of the NIH stroke scale.

Authors:  L B Goldstein; C Bertels; J N Davis
Journal:  Arch Neurol       Date:  1989-06

4.  A blinded randomized assessment of laser Doppler flowmetry efficacy in standardizing outcome from intraluminal filament MCAO in the rat.

Authors:  Hideki Taninishi; Jin Yong Jung; Miwa Izutsu; Zhengfeng Wang; Huaxin Sheng; David S Warner
Journal:  J Neurosci Methods       Date:  2014-12-17       Impact factor: 2.390

5.  Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Statistical validation.

Authors:  J H Garcia; S Wagner; K F Liu; X J Hu
Journal:  Stroke       Date:  1995-04       Impact factor: 7.914

6.  Intraischemic nitrous oxide alters neither neurologic nor histologic outcome: a comparison with dizocilpine.

Authors:  Noriko Yokoo; Huaxin Sheng; Javier Mixco; H Mayumi Homi; Robert D Pearlstein; David S Warner
Journal:  Anesth Analg       Date:  2004-09       Impact factor: 5.108

7.  Improved reliability of the NIH Stroke Scale using video training. NINDS TPA Stroke Study Group.

Authors:  P Lyden; T Brott; B Tilley; K M Welch; E J Mascha; S Levine; E C Haley; J Grotta; J Marler
Journal:  Stroke       Date:  1994-11       Impact factor: 7.914

8.  Results of a preclinical randomized controlled multicenter trial (pRCT): Anti-CD49d treatment for acute brain ischemia.

Authors:  Gemma Llovera; Kerstin Hofmann; Stefan Roth; Angelica Salas-Pérdomo; Maura Ferrer-Ferrer; Carlo Perego; Elisa R Zanier; Uta Mamrak; Andre Rex; Hélène Party; Véronique Agin; Claudine Fauchon; Cyrille Orset; Benoît Haelewyn; Maria-Grazia De Simoni; Ulrich Dirnagl; Ulrike Grittner; Anna M Planas; Nikolaus Plesnila; Denis Vivien; Arthur Liesz
Journal:  Sci Transl Med       Date:  2015-08-05       Impact factor: 17.956

9.  Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination.

Authors:  J B Bederson; L H Pitts; M Tsuji; M C Nishimura; R L Davis; H Bartkowski
Journal:  Stroke       Date:  1986 May-Jun       Impact factor: 7.914

10.  A concerted appeal for international cooperation in preclinical stroke research.

Authors:  Ulrich Dirnagl; Antoine Hakim; Malcolm Macleod; Marc Fisher; David Howells; Stuart M Alan; Gary Steinberg; Anna Planas; Johannes Boltze; Sean Savitz; Costantino Iadecola; Stephen Meairs
Journal:  Stroke       Date:  2013-04-18       Impact factor: 7.914

View more
  3 in total

1.  2-(4-Methoxyphenyl)Ethyl-2-Acetamido-2-Deoxy-β-D-Pyranoside Exerts a Neuroprotective Effect through Regulation of Energy Homeostasis and O-GlcNAcylation.

Authors:  Hui Xu; Huaxiang Gu; Yanhong Yang; Ergai Cai; Fei Ding; Shu Yu
Journal:  J Mol Neurosci       Date:  2019-06-15       Impact factor: 3.444

2.  Chemogenetics-mediated acute inhibition of excitatory neuronal activity improves stroke outcome.

Authors:  Ya-Chao Wang; Francesca Galeffi; Wei Wang; Xuan Li; Liping Lu; Huaxin Sheng; Ulrike Hoffmann; Dennis A Turner; Wei Yang
Journal:  Exp Neurol       Date:  2020-01-18       Impact factor: 5.330

3.  Activation of the ATF6 branch of the unfolded protein response in neurons improves stroke outcome.

Authors:  Zhui Yu; Huaxin Sheng; Shuai Liu; Shengli Zhao; Christopher C Glembotski; David S Warner; Wulf Paschen; Wei Yang
Journal:  J Cereb Blood Flow Metab       Date:  2016-07-20       Impact factor: 6.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.